Full Buyout
MCA & GST VerifiedDD Ready VaultHigh ROI Opportunity
Project PharmaSterile

USFDA-Ready Sterile Injectables & Liquid Oral Formulations Manufacturing Plant

WHO-GMP Certified Facility with 24 Export Dossiers & Strong Domestic Institutional Supply

Healthcare & PharmaChennai, Tamil NaduEst. 2008 (16 yrs)140 Full-Time Employees36 views today
USFDA-Ready Sterile Injectables & Liquid Oral Formulations Manufacturing Plant
97% AI Match ScoreExcellent Deal Health
Asking Valuation
₹55.0 Cr3.47x EBITDA
Annual Revenue₹72.0 Cr
EBITDA₹15.84 Cr
EBITDA Margin22%
Net Profit₹11.5 Cr
Seller Representation:Investment Bank Advisor
Advisor Response Rate:95% within 3 hours
Audited Documents:26 Confidential Files

Executive Summary

State-of-the-art sterile injectables and specialized liquid formulation pharmaceutical manufacturing plant. Holds WHO-GMP, EU-GMP compliant design, and export registrations across Southeast Asia, Africa, and CIS nations.

Key Investment Highlights & Competitive Moats

Annual capacity of 60 million ampoules and 40 million sterile vials with automated Bosch filling lines
Over 120 approved drug formulation dossiers with domestic state government tender rate contracts
4-Acre freehold industrial campus with dedicated cleanrooms (Class 100 / Grade A isolators) and zero discharge ETP
Strong historical 16-year profitability with zero FDA 483 observations

Identified Growth Corridors & Upside Potential

USFDA inspection audit scheduled; successful clearance will unlock US generic markets
Contract manufacturing pipeline for major multinational pharmaceutical brands

Hard Assets, Real Estate & IP Included in Sale

  • 4-Acre SIPCOT industrial plot and 65,000 sq.ft cleanroom building
  • Automated Bosch & Rommelag sterile blow-fill-seal lines
  • Full QC/QA analytical testing laboratory with HPLC & GC-MS suites
  • Active drug licenses, product registrations, and customer contracts

Reason for Divestment / Capital Raise

Corporate divestment; parent group focusing on active pharmaceutical ingredients (API).

Similar Verified Opportunities

Curated deals matching similar industry and EBITDA parameters.

Explore All Deals
Accredited 4-Center Chain of Super-Speciality Ophthalmology & Laser Clinics
Hot DealPartial Equity
93% AI MatchExcellent Health
VerifiedDD ReadyHigh ROI
Revenue₹41.0 Cr
EBITDA₹13.12 Cr
EBITDA Margin32%
Multiple2.44x EBITDA
8 yrs • 110 team46 views today
Asking Price₹32.0 Cr
Listed 7d ago
Details
5-Star Backwater Boutique Eco-Resort & Certified Ayurvedic Wellness Spa
Hot DealFull Buyout
95% AI MatchExcellent Health
VerifiedDD ReadyHigh ROI
Revenue₹12.5 Cr
EBITDA₹5.25 Cr
EBITDA Margin42%
Multiple8.0x EBITDA (Prime Waterfront Real Estate)
7 yrs • 68 team33 views today
Asking Price₹42.0 Cr
Listed 8d ago
Details
Profitable B2B Precision CNC Auto-Components & Aerospace Machining Unit
Hot DealFull Buyout
96% AI MatchExcellent Health
VerifiedDD ReadyHigh ROI
Revenue₹26.5 Cr
EBITDA₹6.36 Cr
EBITDA Margin24%
Multiple2.91x EBITDA
13 yrs • 84 team38 views today
Asking Price₹18.5 Cr
Listed 4d ago
Details